
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Elev8 Venture Partners is a Bengaluru-based growth-stage venture capital firm founded in 2022. The firm was established to address the funding gap for startups in India, particularly those seeking Series B and C funding rounds. Elev8 focuses on empowering entrepreneurs and high-growth businesses, especially in the technology sector. The firm is backed by KB Investment, part of KB Holdings, which provides strategic support and opportunities for cross-border expansion.
Currently, Elev8 manages assets totaling approximately $200 million. The firm has closed its first fund at ₹1,400 crore (around $160 million) in August 2025, with a pro-rata fund structure that allows participation in follow-on rounds. Elev8 aims to build a portfolio of 12 to 14 companies per fund, with check sizes ranging from $8 million to $14 million. The firm has established a strong reputation in the Indian growth-stage ecosystem, supported by a diverse LP base that includes investors from Korea and Hong Kong.
Elev8 Venture Partners primarily invests in technology-driven companies across several sectors, including consumer internet, SaaS, B2B platforms, and fintech. The firm targets startups that are poised for significant growth and are seeking capital to scale their operations, particularly in Series B and C funding rounds. Elev8 emphasizes sectors that enhance consumer convenience, drive automation, and optimize supply chains.
The firm looks for companies with valuations between $100 million and $500 million, focusing on those that demonstrate strong growth potential and innovative solutions. Elev8's investment strategy includes a hands-on approach, providing strategic support and leveraging its extensive network to enhance portfolio companies' growth trajectories. The firm actively participates in follow-on funding rounds, ensuring continued support for its investments.
Elev8 Venture Partners has invested in a diverse range of technology-driven companies, with notable portfolio companies including:
Among these, ReshaMandi stands out as a notable exit, showcasing Elev8's ability to identify and support high-potential startups. The firm aims to expand its portfolio further, focusing on technology-driven businesses that align with its investment thesis.
Navin Honagudi: Managing Partner with over 16 years of experience in venture capital and private equity. He co-founded Kae Capital and has backed notable companies such as Healthkart and Zetwork.
Parth Doshi: Vice President with expertise in technology investments and a background in finance.
Abhinav Vinay: Analyst specializing in market research and portfolio analysis.
Mayank Jajoo: Finance Executive responsible for financial management and reporting.
Ashwini Khemka: CFO with extensive experience in financial strategy and operations.
Ashpi Gupta: Principal focusing on investment strategy and portfolio management.
Umang Saraf: Associate involved in deal sourcing and due diligence.
Abhisekh Shah: Principal with a strong background in technology investments.
Komal Vichoor: Analyst supporting investment analysis and research.
Deepika Surana: Investor Relations Specialist managing communications with investors and stakeholders.
To pitch Elev8 Venture Partners, startups should use the preferred channel of their website or email. The pitch deck should include a clear overview of the business model, market opportunity, and financial projections. Founders should expect a response within a few weeks, and warm introductions are highly recommended to increase the chances of engagement.
In March 2026, Elev8 Venture Partners made a significant investment of Rs 300 crore in Fullife Healthcare, marking its first direct-to-consumer investment. This investment highlights the firm's commitment to supporting innovative health and wellness brands.
As of September 2025, Elev8 disclosed its initial five portfolio companies, which include Smallcase, IDfy, AstroTalk, Snapmint, and Porter. These companies represent a diverse range of sectors, showcasing Elev8's focus on technology-driven growth.
In August 2024, Elev8 successfully exited its investment in ReshaMandi, demonstrating its ability to identify and support high-potential startups.
What are Elev8 Venture Partners' investment criteria?
Elev8 Venture Partners invests in technology-driven companies primarily in the consumer internet, SaaS, fintech, and healthcare sectors. The firm targets startups in Series B and C funding rounds, focusing on those with valuations between $100 million and $500 million.
How can startups apply or pitch to Elev8?
Startups can pitch to Elev8 Venture Partners through their website at elev8vp.com or by emailing info@elev8vp.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Elev8 Venture Partners different from other VCs?
Elev8 focuses specifically on bridging the funding gap for growth-stage startups in India, particularly in technology sectors. Their backing from KB Holdings provides additional strategic support and opportunities for cross-border expansion.
What is Elev8's geographic scope?
The firm primarily invests in startups based in India and Asia, with a strong emphasis on the Indian market.
What is Elev8's post-investment involvement like?
Elev8 actively participates in follow-on funding rounds and provides strategic guidance to help entrepreneurs navigate growth challenges. The firm leverages its extensive network to enhance the growth trajectories of its portfolio companies.
What is the typical check size for Elev8's investments?
Elev8 Venture Partners typically invests between $8 million and $14 million in each portfolio company, depending on the specific needs and growth potential of the startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.